Aarti Drugs advanced 2.11% to Rs 405.80 after the pharmaceutical company's consolidated net profit rose 1.04% to Rs 37.05 crore in Q3 FY25, compared with Rs 36.67 crore recorded in Q3 FY24.
As a daily pill-taker, I’ve learned that the phrase “Out of sight, out of mind” holds all too true when it comes to staying on top of my medications. A pill case that looks and feels nice ...